TABLE 5 ] .
θ During Quiet Breathing | θDIA, ° | θDIA Treated (or Worst Affected) Side, ° | θDIA Untreated Side, ° | |||||||||
Pre | Post | Change | P Valuea | Pre | Post | Change | P Value | Pre | Post | Change | P Valuea | |
LVRS | –36.2 ± 39.7 | –7.3 ± 16.1 | 28.9 ± 24.1 | .004 | –42.1 ± 31.1 | –9.3 ± 20.7 | 32.8 ± 22. | .004 | –32.8 ± 28.5 | –19.4 ± 31.2 | 13.5 ± 51.2 | .25 |
BLVR | –54.4 ± 44.7 | –26.4 ± 10.0 | 28.0 ± 38.6 | .11 | –51.4 ± 45.3 | –21.4 ± 10.1 | 30.0 ± 45.3 | .11 | –55.7 ± 42.6 | –39.4 ± 27.9 | 16.4 ± 44.7 | .47 |
All LVR | –44.1 ± 36.8 | –15.7 ± 16.5 | 28.5 ± 30.1 | .002 | –46.1 ± 36.9 | –14.6 ± 17.6 | 31.6 ± 33.1 | .003 | –42.9 ± 36.0 | –28.1 ± 30.6 | 14.8 ± 46.9 | .16 |
Control subjects | –30.1 ± 35.4 | –36.0 ± 36.4 | –6.0 ± 51.9 | .49 | –27.0 ± 35.4 | –38.2 ± 40.8 | –11.2 ± 47.7 | .32 | –34.3 ± 37.5 | –39.6 ± 38.6 | –5.4 ± 59.1 | .38 |